Obesity, the most common nutritional problem in Western societies, is caused by a sustained imbalance of food intake and energy expenditure. A long-term reduction in energy dissipation could therefore be a predisposing factor for this disorder. Indeed, a decrease in the resting metabolic rate is a risk factor for obesity [1, 2] and genetic factors appreciably contribute to the magnitude of the basal metabolic rate [3, 4] . Brown adipose tissue (BAT) is specialized for thermogenesis, a chief determinant of energy expenditure [5] . Central to BAT-function is the uncoupling protein-1 (UCP1) which stimulates heat production by uncoupling substrate oxidation from ATP synthesis [6] . Although the importance of BAT as a regulator of body fat stores has been established in rodents [7, 8] , its role in human obesity is not clear because adult humans possess very little BAT [9] . Notwithstanding this qualification, considerably less mRNA Diabetologia (1999) Abstract Aims: Uncoupling protein-3 is a member of a protein family that serves to dissipate energy in the form of heat thereby modulating energy expenditure. Alternative processing of uncoupling protein-3 transcripts results in two mRNA species that encode a large and small protein, perhaps differing in functional activity. Since obesity is associated with disrupted energy homeostasis, we measured muscle mRNA expression in morbidly obese and lean subjects.
of the BAT-specific UCP1 have been observed in the intraperitoneal adipose tissue of obese than in lean control subjects [10] . A contribution of UCP1 and BAT to energy expenditure in humans is therefore conceivable.
Two other recently discovered members of a mitochondrial carrier superfamily, UCP2 and UCP3, are more widely expressed in humans and in rodents. Uncoupling protein-2 mRNA is found in white adipose tissue, BAT, lung, liver, spleen and macrophages [11, 12] and high expressions of UCP3 mRNA are observed in skeletal muscle and BAT [13±15] . Although direct evidence for a thermoregulatory function of UCP3 has not been presented, this protein could be implicated in energy homeostasis because muscle tissue accounts for a large portion of catecholamine and diet-induced thermogenesis in both humans [16] and rats [17] . Both the human UCP2 and UCP3 gene have been mapped to chromosome 11q13 [12, 18, 19] . Linkage analysis in pedigrees of the Quebec Family Study provided strong evidence for an association of this chromosomal region with resting metabolic rate, body mass index (BMI) and fat mass in adult humans [20] . In addition, the syntenic region on mouse chromosome 7 is coincident with quantitative trait loci for obesity and Type 2 (non-insulin-dependent) diabetes mellitus [21, 22] .
In comparison with lean controls, UCP2 mRNA abundance was reduced in intraperitoneal adipose tissue of morbidly obese subjects and UCP2 mRNA expression remained low in post-obese subjects studied before and after weight reduction [23] . By contrast, UCP3 mRNA expression in muscle tissue did not differ between obese and lean subjects [24] . Unexpectedly, UCP3 mRNA expression increased after short-term fasting. Owing to alternative polyadenylation/splicing, UCP3 mRNA occurs in two isoforms termed UCP3 L and UCP S mRNA [14, 18] . Because of a C-terminal truncation, UCP3 S lacks the sixth predicted transmembrane domain and a purine nucleotide binding domain implicated in nucleotide-mediated inhibition of UCP-activity [25] . Thus UCP3 S could possess enhanced activity but faulty membrane insertion might compromise its stability and function. In a follow-up study, it was suggested that UCP3 transcript processing is not altered in obese people because using an RT-PCR method for quantification, equimolar abundance of UCP3 L and UCP3 S mRNA was found in muscle tissue of both obese and lean subjects [26] .
To study the role of UCP3 in human obesity and energy metabolism, we quantified UCP3 S and UCP3 L mRNA expression in skeletal muscle of obese, post-obese and lean subjects by RNase protection assay and studied allele-specific expression in an attempt to identify mutations at the UCP3 gene locus that affect mRNA expression.
Subjects and methods
Study subjects, skeletal muscle and intraabdominal fat tissue samples. Tissue samples were obtained from musculus rectus abdominis of 38 morbidly obese subjects who underwent weight reduction surgical treatment through a gastric banding procedure. In seven of these subjects, muscle tissue was also obtained during an elective surgical procedure 9 ± 5 (means SD) months after the gastric banding surgery. Fifteen control subjects and ten post-obese subjects, not sampled during the initial weight reducing surgery, underwent elective surgical procedures such as cholecystectomy, repair of hernias and adjustment or removal of the gastric tape. Study subjects gave informed consent and the study was approved by the institutional review board. After an overnight fast general anaesthesia was induced by a short-acting barbiturate and maintained by alfentanil-hydrochloride. Tissue biopsies were taken at the beginning of the surgical procedure, divided into aliquots and frozen at ±70°C. Body mass index (BMI, kilograms per meter squared) was calculated from measurements of weight and height.
Clinical procedure. After an overnight fast, venous blood was collected into tubes containing EDTA. Plasma glucose was measured by a hexokinase/glucose-6-phosphate dehydrogenase method (Boehringer Mannheim Diagnostics, Mannheim, Germany). Plasma insulin was measured by immunoassay (MEIA, Abbott Laboratories, Abbott Park, Ill., USA). Plasma non-esterified acids were determined by an enzymatic colorimetric method (Boehringer Mannheim Diagnostics). Plasma leptin concentrations were measured with a RIA kit (Linco, St. Charles, Mo., USA).
Isolation of DNA and skeletal muscle and adipose tissue total RNA. We isolated Genomic DNA from peripheral leucocytes using the QIAamp Blood Kit (Qiagen, Hilden, Germany) and RNA from 0.5 g of human skeletal muscle according to a previously described method [27] . The integrity of RNA samples was ascertained by their electrophoretic pattern in formaldehyde gels. Concentrations of RNA were determined by absorbance measurements at 260 nm.
Quantification of total UCP3, UCP3 S and UCP3 L mRNA by RNase protection assay. Fragments of cDNA spanning exon 6 and 7 were amplified by RT-PCR. 5 ¢-CCCCTGCCACT-TTGTCTCTG-3 ¢ ( + 651 to + 670) as sense and 5 ¢-CAC-CGTTTTCTTCCATTCTT-3 ¢ ( + 1016 to + 1036) or 5 ¢-TC-CCTAACCCTCCCCATCAG-3 ¢ ( + 985 to + 1004) as antisense primers were used for UCP3 L and UCP3 S , respectively. The numbers in parentheses designate the position of the primers relative to the translation start site (GenBank Accession Nr. U84 763 for UCP3 L and U82 818 for UCP3 S ). Fragments of PCR were cloned into pGEM3Zf(+ P-labelled RNA-RNA hybrids were precipitated, subjected to electrophoresis in 4 % polyacrylamideurea gels and quantified by scanning of autoradiographs with a Model GS-700 Imaging densitometer using the Molecular Analyst software (Bio-Rad, Hercules, Calif., USA). Tissue UCP3 mRNA expression was calculated using a standard curve that was constructed by plotting signal intensities of 3 Hlabelled UCP3 L or UCP3 S against the respective doses. We corrected UCP3 mRNA results for cyclophilin A [28] mRNA abundance determined by RNase protection assay using a 122 nt cyclophilin antisense probe spanning nucleotides + 189 to + 310 relative to the transcription start site (GenBank Accession Nr. Y00 052).
Allele-specific gene expression studies. Primer extension was used to quantify UCP3 mRNA transcribed from the wild-type and variant allele harbouring a T/C substitution at position + 297 relative to the translation start site [29] . To type the T/C substitution, genomic DNA was amplified by PCR using 5 ¢-TGGACTGAAGCCTTCAGACGTG-3 ¢ and 5 ¢-ACA-ACAGTTCTGTAAACATGTG-3 ¢ ( + 159 to + 180 and + 1189 to + 1207, Genbank Accession Nr. U84 763) as sense and antisense primer. Reactions of PCR contained 0.2 mmol/l of each upstream and downstream primer, 200 mmol/l of dNTPs, 10 mmol/l Tris, pH 8.3, 50 mmol/l KCl, 2.5 mmol/l MgCl 2 and 1 unit of Taq-Polymerase (Perkin-Elmer Applied Biosystems, Foster City, Calif., USA). The PCR included 35 cycles of 94°C/56°C/72°C, each for 1 min. Gel-purified PCR products were sequenced using the PRISM Ready Reaction dRhodamine-Terminator kit and an ABI Prism 310 Genetic Analyzer (Perkin-Elmer). For primer extension studies, total skeletal muscle RNA (1 mg) was reverse transcribed using the random-hexamer priming method. Aliquots of cDNA were subjected to PCR to generate a 377 bp fragment. The forward 5 ¢-biotinylated exon 2 primer was 5 ¢-TGGGCAGA-GCCTTCCAGGAC-3 ¢ ( + 133 to + 152, GenBank Accession Nr. U84 763) and the reverse exon 3 to exon 4 junction primer was 5 ¢-CGGGTAGTGAGGCTGGAGTTGT-3 ¢ ( + 488 to + 509). The PCR reactions contained the reaction components described above and included 35 cycles of 94°C/60°C/ 72°C, each for 1 min. Transcripts of UCP1 and UCP2 were excluded to confound allele-specific studies, as 10 fg of UCP1 or UCP2 template cDNA did not produce amplification products in the UCP3-specific PCR. We isolated ssDNA using streptavidin-coated magnetic beads (Dynal A. S., Oslo, Norway). Primers for wild-type and mutant allele-specific extension were 5 ¢-GTACACCTGCTTGACGGA-3 ¢ ( + 454 to + 471) and 5 ¢-TACACCTGCTTGACGGAG-3 ¢ ( + 453 to + 470), respectively. Extension reactions and quantification of extension products were done exactly as described [30] . For assay standardization, cDNAs of two patients, carrying either two wildtype or two mutant alleles were amplified using Pfu-Polymerase (Stratagene, La Jolla, Calif., USA) and blunt-end cloned using the ZERO-Background cloning system (Invitrogen, Carlsbad, Calif., USA). Various mixtures of plasmids containing the wild-type and mutant allele as inserts served as templates for PCR amplification and subsequent primer extension to generate a standard curve that compared molar ratios of templates with their signal intensity ratios.
Statistical analysis. Both ANOVA [31] and a more robust nonparametric test, the Kruskal Wallis test [32] , were used to examine the equality of continuous variables such as age and biochemical measurements between obese and non-obese male or female subjects. A transformation was made on the original variable, if the equal variance and normality assumptions of the one-way ANOVA were rejected. For comparison of categorical variables, a contingency chi-squared test was used. Agreement of genotype-frequencies with Hardy-Weinberg equilibrium was tested using a chi-squared goodness-of-fit test. The paired t-test was used to analyse UCP3 mRNA expression before and after weight reduction surgery. Multivariate regression analysis with sex and BMI as independent and leptin values as dependent variables was done in a large population including obese and normal subjects studied previously [10, 23, 30, 33] to predict plasma leptin concentrations in postobese subjects.
Results
The BMI of obese patients was almost twice that of control subjects in both sexes ( Table 1 ). The average age of obese and non-obese men was similar but was lower in obese women than in non-obese women. In both sexes obese subjects had higher average plasma concentrations of insulin and leptin than control subjects whereas average glucose concentrations were similar in both groups. The RNase protection assays with the 32 P-UCP3 L antisense RNA probe containing 174 nt of exon 6 and 180 nt of exon 7 showed two protected fragments consisting of 354 nt and 174 nt, respectively. The larger fragment represented UCP3 L and the smaller UCP3 S (Fig. 1) . The average abundance of UCP3 S was about 2.5 times higher than that of UCP3 L in both obese and lean study subjects. Total UCP3 mRNA expression as well as that of UCP3 L and UCP3 S , all corrected for cyclophilin mRNA abundance, were not different in lean and obese women, although the difference between lean and obese men approached statistical significance (Table 2). Median expression of UCP3 mRNA was also similar in obese and lean subjects, stratified by sex and no difference was observed between men and women. No significant difference in the molar ratio of UCP3 L to UCP3 S was noted in our study groups. An inverse association between total UCP3 mRNA and the molar UCP3 L to UCP3 S ratio was, however, observed in obese subjects only (r = 0.4829, n = 38, p < 0.005). Total UCP3 mRNA levels exhibited a correlation with plasma fatty acids in lean (r = 0.483, p < 0.023), but not in obese subjects.
Muscle UCP3 mRNA expression was determined in 7 of the 38 obese subjects 3 to 18 months after the gastric banding surgery. The BMI and plasma concentrations of leptin and insulin decreased between the surgical procedures, whereas no changes in plasma non-esterified fatty acid and glucose concentrations were noted (Table 3) . A decrease in UCP3 L and UCP3 S mRNA expression was observed at the time of the second surgical procedure but molar transcript ratios of UCP3 L to UCP3 S remained unchanged (Fig. 1, Table 3 ). To estimate the calorie intake status of these subjects at the time of the surgical procedures, plasma leptin concentrations were compared with those predicted from multivariate analysis in a group of 497 subjects at their usual weight with BMIs ranging from 17.5 to 64.3. Body mass index and sex accounted for 61 % of the variance of leptin in this group. In our seven patients, the average (SD) leptin was 81 (30)% of that predicted at the initial weight reducing surgery but was decreased to 28 (14)% (p < 0.01) of that predicted at the second surgical procedure, strongly suggesting hypocaloric intake in the post-obese state. Muscle UCP3 mRNA expression was also measured in ten post-obese women from whom muscle biopsies had only been obtained during the second elective surgery. The BMI in these patients had decreased from 44.7 ± 4.2 to 30.9 ± 4.6 kg/m 2 over a period of 34 ± 19 months. Expression of UCP3 L and UCP3 S was 0.17 ± 0.05 and 0.38 ± 0.14 mol/mol cyclophilin mRNA, respectively. These values differed from the UCP3 expression in lean (p < 0.05) and obese women (p < 0.005) shown in Table 2 . The measured leptin in these subjects was 66 (27)% of that predicted. Thus, the decline in muscle UCP3 expression in both study groups cannot be attributed to the post-obese state per se, but could reflect a prolonged hypocaloric intake.
To estimate the contribution of the UCP3 gene locus to the interindividual variability of UCP3 mRNA expression (Table 2) , we measured allele-specific mRNA expression in subjects heterozygous for a silent T/C polymorphism at position + 297 relative to the translation start site (Fig. 2) . The estimated frequencies of the T and C alleles in our study group were 0.798 and 0.202, respectively. The observed genotype frequencies agreed with Hardy-Weinberg expectations. Using mixtures consisting of different molar ratios of wild-type and variant cDNA, a linear relation (r = 0.96, p < 0.001) was found between molar input ratios and signal intensity ratios of extension products (Fig. 2C) . The coefficient of variation, determined in equimolar mixtures of wild-type and variant templates, was 4 %. Thus, primer extension allowed reliable quantitation of mRNA species transcribed from the two UCP3 alleles. In only one obese subject, the wild-type to variant transcript abundance ratio of 1.17 exceeded the threefold assay variability. In the UCP3 mRNA expression was determined in skeletal muscle tissue samples of lean and obese human subjects using an RNase protection assay. UCP3 mRNA abundance was normalized for cyclophilin mRNA abundance.
Results are expressed as means ± SD and represent mol UCP3 mRNA/mol cyclophilin mRNA or mol UCP3 L /mol UCP3 S . a Analysis of variance within the respective sex group Clinical and biochemical characteristics of 5 female and 2 male subjects before and after weight reducing surgery are shown. Surgery I refers to the initial weight reduction surgery and surgery II refers to an elective surgical procedure done 9 ± 5 months later. UCP3 mRNA expression is shown as mol/mol cyclophilin mRNA. a p < 0.0001, b p < 0.05, paired t -test remaining subjects, 16 obese, 1 post-obese and 5 nonobese, displaying UCP3 mRNA abundance between 0.36 and 1.79 mol/mol cyclophilin mRNA, the average molar ratio of wild-type to variant transcript was 0.97 (SD 0.03, range 0.89±1.06). Thus, the small deviation from unity in the transcript ratio of some subjects was within the analytical variation. Minor differences in allele-specific expression can therefore not be excluded.
Discussion
A large portion of the variance in resting energy expenditure among humans has been accounted for by differences in fat-free mass, much of which consists of skeletal muscle [34] . Because of its abundant expression in skeletal muscle, UCP3 is a potential candidate for the proton leak that might contribute appreciably to resting metabolic rate and total energy expenditure. Similar expression of UCP3 mRNA have been reported in muscle tissues of obese and lean people [24] . Although our gender-specific analyses showed marginally higher expression in morbidly obese than in lean men, our findings generally support these earlier results [24] and argue against abnormalities in UCP3 mRNA expression in obese subjects. An altered protein or activity level of UCP3 in obesity cannot, however, be excluded as translational and post-tranlational events could vary and the concentration of metabolites activating or inhibiting uncoupling activity could differ between obese and Fig. 1A±C . Quantification of UCP3 L and UCP3 S mRNA by RNase protection assay in skeletal muscle before and after weight loss. A Structural relation of antisense probe complementary to exon 6 and 7 sequences with UCP3 L and UCP3 S mRNA structure; AATAAA S and AATAAA L refer to previously described polyadenylation signals used for the generation of UCP3 L and UCP3 S mRNA. The hatched box indicates intron 6 sequences present in UCP3 S mRNA. B Autoradiograph of RNase protection assay; M, end-labelled size marker containing the number of nucleotides indicated; 1, undigested 32 P-UCP3 antisense probe; 2, 32 P-UCP3 antisense probe hybridized to yeast RNA and subjected to RNase digestion; 3±5, RNase protection assay of 10 mg of skeletal muscle total RNA from three obese subjects before (a) and after (b) weight loss subsequent to the gastric banding procedure. Protected fragments representing UCP3 L and UCP3 S mRNA are indicated on the right. RNase protection assays using a cyclophilin antisense mRNA was used for UCP3 mRNA normalization (lower panel). C Standardization of RNase protection assays using increasing amounts of 3 H-labelled UCP3 L (left), UCP3 S (middle) and cyclophilin sense RNA (right). Molar input of sense RNA was plotted against optical density (OD) values determined by scanning autoradiographs lean humans. Nevertheless, the similar UCP3 mRNA expression in muscle of lean and obese subjects is consistent with studies showing that resting metabolic rate and total energy expenditure per unit of fat-free body mass are similar in lean and obese subjects [35] .
Our study shows that UCP3 L was the less abundant transcript species in all subjects studied. This result is at variance with another study showing equimolar abundance of UCP3 L and UCP3 S in obese and lean subjects [26] . Consistent with the study of Millet et al. [24] , the molar ratio of UCP3 L to UCP3 S was similar in all study groups (Fig. 1, Tables 2, 3 ) suggesting no alteration in transcript processing in obese subjects. The moderate inverse association, observed within the obese group only, between UCP3 mRNA abundance and molar transcript ratio suggests a saturable process of UCP3 L generation.
To gain further insight into a possible role of UCP3 in human energy homeostasis, we determined mRNA expression in subjects who experienced a substantial weight loss after the gastric banding surgery. The decrease of UCP3 transcripts observed in post-obese subjects probably reflected prolonged hypocaloric intake, since the plasma leptin concentrations in these patients were lower than those predicted for their BMI. Such a conclusion would be consistent with recent studies showing a reduction of energy expenditure during or after weight loss [36, 37] . Prospective data in Pima Indians established an association of hypoleptinaemia with future weight gain [38] . The subnormal leptin concentrations in our post-obese subjects could have resulted from a defect in the regulation of leptin rather than from a hypocaloric diet but the similarity of measured and predicted leptin in these patients prior to the weight reducing surgery is an argument against this suggestion. Nevertheless, the model of leptin prediction included obese subjects perhaps defective in adequate upregulation of leptin expression. Hence, the possibility cannot be excluded that obesity with its attendant metabolic changes enhanced UCP3 mRNA expression in some subjects, thereby masking inherent defects in UCP3 expression.
Expression of UCP3 mRNA in muscle of obese and lean subjects was augmented in response to a 5-day calorie restriction [24] . Fasting for 24 or 48 h increased, but a 50 % food restriction for 1 week decreased muscle UCP3 mRNA abundance in rats [15, 39] . Hence, changes in metabolite concentrations related to the duration of food restriction could be critical determinants of UCP3 gene expression. Fatty acids have been suspected to influence UCP3 gene expression [40] . In our study, plasma fatty acid concentration displayed a moderate correlation with UCP3 mRNA abundance in lean subjects only and plasma fatty acid concentrations were similar in obese patients before and after weight reduction. Thus, additional factors need to be invoked to ex- Fig. 2A±C . UCP3 allele-specific expression studies using variant-specific primer extension. A Experimental strategy showing use of a biotinylated sense primer for RT-PCR (top), capture of the amplified UCP3 sense strand via streptavidin beads (middle) and primer extension using ddGTP (bottom). Arrows indicate the extension products predicted for wildtype and mutant templates. B Autoradiogram of primer extension products as schematized in A. Lanes 1±9 show 32 P-labelled primer, extension products of cloned wild-type and variant cDNA, mixtures of wild-type and variant cDNA in molar ratios of 3, 1, and 0.33, respectively, skeletal muscle total RNA from two obese subjects and DNA of a subject heterozygous for the T/C substitution in exon 3. C Standard curve of the primer extension assay constructed by analysing five different mixtures of cloned UCP3 wild-type and variant alleles (r = 0.96, p < 0.001). The slope and intercept of the regression line was 0.53 and 0.18, respectively. Molar input ratios were plotted against signal intensity ratios determined by scanning autoradiographs plain the downregulation of UCP3 expression in our post-obese patients. In obese subjects, weight loss caused by a prolonged low-calorie diet enhanced muscle dynamic endurance, improved the fractional velocity of contraction and reduced the rate of glucose oxidation [41] . In addition, UCP3 and UCP2 expression decreased in response to endurance training in rats [42] . Thus, the need for a higher metabolic efficiency as exemplified by prolonged calorie restriction or endurance training might be conducive to downregulation of muscle UCP3 expression which would be predicted to reduce energy dissipation in these tissues.
Since muscle UCP3 mRNA abundance displayed considerable variability among subjects, we determined whether cis-regulatory elements would account for part of this variability. Such an approach was used previously to show that sequence variations at the UCP1 gene locus accounted for a large portion of the mRNA expression variance in obese subjects [30] . Only one of 23 subjects, however, displayed an allelic difference in UCP3 mRNA abundance. Differences in trans-acting factor activities must therefore have accounted for most of the interindividual variability in UCP3 mRNA expression and differences in cis-regulatory elements must have played a minor part. We have sequenced the UCP3 promoter and identified, by computational analyses, consensus sequences for trans-acting factor binding sites including three clustered E-box motifs, a peroxisome proliferator-activated receptor g/retinoid X receptor response element and a thyroid response element (Esterbauer H, Oberkofler H, Patsch W, unpublished observation).
In summary, our studies suggest that human obesity is not associated with alterations of UCP3 mRNA expression or transcript processing. Sequence substitutions at the UCP3 gene locus affecting its mRNA expression in muscle are probably uncommon in the Austrian population. The reduction in muscle UCP3 mRNA expression that occurred in our postobese patients could contribute to the reduced energy expenditure that has been reported after prolonged fasting [36, 37] .
